Resultados de la búsqueda filtrada
Los productos de algunos de nuestros proveedores no aparecen en los resultados de la búsqueda filtrada. Por favor,
borre todos los filtros
para ver estos productos.
1
–
15
de
24,581
resultados

Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
Sistema de expresión | E. coli |
---|---|
Nombre | Human EGF, Animal-Free |
Nombre común | EGF |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | EGF |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 1950 |
Concentración de endotoxinas | <0.1 EU/ μg |
Número de acceso | P01133 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 6.2 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
Alias de gen | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
Actividad biológica | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | Functional Assay |
Sistema de expresión | E. coli |
---|---|
Nombre | Human IFN-gamma |
Nombre común | IFN gamma |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | IFNG |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 3458 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P01579 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 16.8 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
Alias de gen | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN ?; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFN?; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon ?; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferon?; M-IFN-g; R-IFN-g |
Actividad biológica | The ED50 determined by a cytotoxicity assay using HT-29 cells is = 0.05 ng/ml, corresponding to a specific activity of = 2 x 10^7 units/mg |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |
Sistema de expresión | E. coli |
---|---|
Nombre | Human/Mouse/Rat BDNF |
Nombre común | BDNF |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | BDNF |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 12064, 24225, 627 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P21237, P23363, P23560 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 27 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | MHSDPARRGE LSVCDSISEW VTAADKKTAV DMSGGTVTVL EKVPVSKGQL KQYFYETKCN PMGYTKEGCR GIDKRHWNSQ CRTTQSYVRA LTMDSKKRIG WRFIRIDTSC VCTLTIKRGR |
Alias de gen | abrineurin; ANON2; anorexia BDNF; Bdnf; BDNF precursor form; bdnf protein; brain derived neurothrophic factor; brain derived neurotrophic factor; brain-derived neurotrophic factor; BULN2; H-BDNF; neurotrophin; ProBDNF |
Actividad biológica | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |
Sistema de expresión | HEK293 cells |
---|---|
Nombre | Human TGF-beta 1 |
Nombre común | TGF beta-1 |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | Tgfb1 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 7040 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P01137 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 25 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
Alias de gen | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
Actividad biológica | The ED50 was determined by TGF-beta1's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
Estado normativo | RUO |
Fuente | HEK293 cells |
Para utilizar con (aplicación) | Functional Assay |
Sistema de expresión | E. coli |
---|---|
Nombre | Human FGF-basic (FGF-2/bFGF) (154 aa) |
Nombre común | FGF2 |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | FGF2 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 2247 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P09038 |
Grado de pureza o calidad | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 17.2 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
Alias de gen | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
Actividad biológica | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |
Nombre | Human R-Spondin 1 |
---|---|
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | RSPO1 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 284654 |
Número de acceso | Q2MKA7 |
Grado de pureza o calidad | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Secuencia | SRGIKGKRQR RISAEGSQAC AKGCELCSEV NGCLKCSPKL FILLERNDIR QVGVCLPSCP PGYFDARNPD MNKCIKCKIE HCEACFSHNF CTKCKEGLYL HKGRCYPACP EGSSAANGTM ECSSPAQCEM SEWSPWGPCS KKQQLCGFRR GSEERTRRVL HAPVGDHAAC SDTKETRRCT VRRVPCPEGQ KRRKGGQGRR ENANRNLARK ESKEAGAGSR RRKGQQQQQQ QGTVGPLTSA GPA |
Alias de gen | CRISTIN3; cristin-3; cysteine-rich and single thrombospondin domain-containing protein 3; FLJ40906; hRspo1; mCristin-3; RGD1565558; Roof plate-specific spondin-1; RP11-566C13.1; RSPO; RSPO1; Rspondin; R-spondin; R-spondin 1; R-spondin homolog; R-spondin homolog (Xenopus laevis); R-spondin-1; thrombospondin type 1 domain containing gene Rspondin |
Estado normativo | RUO |
Fuente | CHO cells |
Para utilizar con (aplicación) | Functional Assay |
Sistema de expresión | E. coli |
---|---|
Nombre | Human GDNF |
Nombre común | GDNF |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | GDNF |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 2668 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P39905 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 30.4 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | MSPDKQMAVL PRRERNRQAA AANPENSRGK GRRGQRGKNR GCVLTAIHLN VTDLGLGYET KEELIFRYCS GSCDAAETTY DKILKNLSRN RRLVSDKVGQ ACCRPIAFDD DLSFLDDNLV YHILRKHSAK RCGCI |
Alias de gen | AI385739; Astrocyte-derived trophic factor; ATF; ATF1; ATF2; Gdnf; glial cell derived neurotrophic factor; glial cell line derived neurotrophic factor; Glial cell line derived neutrophic factor; glial cell line-derived neurotrophic factor; gndf; HFB1-GDNF; hGDNF; H-GDNF; HSCR3; mGDNF; neurotrophic factor |
Actividad biológica | Determined by a cell proliferation assay using SH-SY5Y cells. The expected ED50 for this effect is 1.0-10.0 ng/ml |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |
Sistema de expresión | E. coli |
---|---|
Nombre | Human IL-4 |
Nombre común | IL-4 |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | Il4 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 3565 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P05112 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 15.1 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | MHKCDITLQE IIKTLNSLTE QKTLCTELTV TDIFAASKNT TEKETFCRAA TVLRQFYSHH EKDTRCLGAT AQQFHRHKQL IRFLKRLDRN LWGLAGLNSC PVKEANQSTL ENFLERLKTI MREKYSKCSS |
Alias de gen | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4 delta2; interleukin 4 variant IL-4 delta3; interleukin 4 variant IL-4 int2A; interleukin 4 variant IL-4 int3A; interleukin 4 variant IL-4 int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
Actividad biológica | The ED50 as determined by the dose-dependent stimulation of human TF-1 cells is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |
Nombre | Human TGF-beta 1 |
---|---|
Formulación | protein with no preservative |
Formulario | Lyophilized |
Secuencia | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
Símbolo de gen | Tgfb1 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
Estado normativo | RUO |
Fuente | CHO cells |
ID de gen (Entrez) | 7040 |
Número de acceso | P01137 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Para utilizar con (aplicación) | Functional Assay |
Sistema de expresión | E. coli |
---|---|
Nombre | Human IL-13 |
Nombre común | IL-13 |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | Il13 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 3596 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P35225 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 12.6 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | MSPGPVPPST ALRELIEELV NITQNQKAPL CNGSMVWSIN LTAGMYCAAL ESLINVSGCS AIEKTQRMLS GFCPHKVSAG QFSSLHVRDT KIEVAQFVKD LLLHLKKLFR EGRFN |
Alias de gen | ALRH; ALRH antibody; BHR1; il 13; Il13; Il-13; IL-13; cytokine; ILN; Interleukin; interleukin 13; Interleukin13; interleukin-13; interleukin-13 precursor; L13; MGC116786; MGC116788; MGC116789; NC30; NC30 antibody; P600; P600 antibody; T-cell activation protein P600 |
Actividad biológica | The ED50 as determined by the dose-dependent proliferation of TF-1 cells was ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |
Nombre | Human BMP-4 |
---|---|
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | BMP4 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 652 |
Número de acceso | P12644 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Secuencia | KKNKNCRRHS LYVDFSDVGW NDWIVAPPGY QAFYCHGDCP FPLADHLNST NHAIVQTLVN SVNSSIPKAC CVPTELSAIS MLYLDEYDKV VLKNYQEMVV EGCGCR |
Alias de gen | BMP; BMP2B; BMP-2 B; Bmp2b1; Bmp2b-1; Bmp4; Bmp-4; BOMPR4A; Bone morphogenetic protein; Bone morphogenetic protein 2 B; bone morphogenetic protein 4; bone morphogenetic protein 4 preproprotein; DVR4; Dvr-4; MCOPS6; OFC11; ZYME |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | Functional Assay |
Sistema de expresión | E. coli |
---|---|
Nombre | Human IL-10 |
Nombre común | IL-10 |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | IL10 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 3586 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P22301 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 18.6 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | MSPGQGTQSE NSCTHFPGNL PNMLRDLRDA FSRVKTFFQM KDQLDNLLLK ESLLEDFKGY LGCQALSEMI QFYLEEVMPQ AENQDPDIKA HVNSLGENLK TLRLRLRRCH RFLPCENKSK AVEQVKNAFN KLQEKGIYKA MSEFDIFINY IEAYMTMKIR N |
Alias de gen | CSIF; cytokine; Cytokine synthesis inhibitory factor; GVHDS; H-IL-10; il 10; IL10; IL-10; IL-10 precursor; IL10A; IL10X; ILN; Interleukin; interleukin 10; Interleukin10; interleukin-10; MGC126450; MGC126451; RP11-262N9.1; T-cell growth inhibitory factor; TGIF |
Actividad biológica | Determined by the dose-dependent co-stimulation (with human IL-4) of MC/9 cells. The ED50 was found to be ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |
Sistema de expresión | E. coli |
---|---|
Nombre | Human TNF-alpha |
Nombre común | TNF alpha |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | Tnf |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 7124 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P01375 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 17.4 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
Alias de gen | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF a; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFa; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1 F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
Actividad biológica | The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |
Thermo Scientific™ Pierce™ Bovine Serum Albumin, Biotinylated
Purified biotin and biotinylated BSA, HRP, AP or FITC for use as controls or to amplify signal in IHC via the avidin-biotin complex (ABC).
Sistema de expresión | E. coli |
---|---|
Nombre | Human GM-CSF |
Nombre común | GM-CSF |
Formulación | protein with no preservative |
Formulario | Lyophilized |
Símbolo de gen | CSF2 |
Recombinante | Recombinant |
Conjugado | Unconjugated |
ID de gen (Entrez) | 1437 |
Concentración de endotoxinas | <1 EU/ μg |
Número de acceso | P04141 |
Grado de pureza o calidad | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Peso molecular | 14.6 kDa |
Contenido y almacenamiento | -20°C |
Secuencia | MAPARSPSPS TQPWEHVNAI QEARRLLNLS RDTAAEMNET VEVISEMFDL QEPTCLQTRL ELYKQGLRGS LTKLKGPLTM MASHYKQHCP PTPETSCATQ IITFESFKEN LKDFLLVIPF DCWEPVQE |
Alias de gen | colony stimulating factor 2; colony stimulating factor 2 (granulocyte-macrophage); colony-stimulating factor; CSF; CSF2; Csfgm; cytokine; GMCSF; Gm-CSf; granulocyte macrophage colony stimulating factor; granulocyte macrophage-colony stimulating factor; granulocyte-macrophage colony stimulating factor 2; granulocyte-macrophage colony-stimulating factor; MGC131935; MGC138897; MGC151255; MGC151257; MGI-IGM; M-GM-CSF; molgramostin; put. GM-CSF; sargramostim |
Actividad biológica | The ED50 as determined by the dose-dependent stimulation of the proliferation of human TF-1 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Estado normativo | RUO |
Fuente | E. coli |
Para utilizar con (aplicación) | ELISA,Functional Assay,Western Blot |